Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats - Psychopharmacology
- ️Pedrosa, Erika
- ️Thu Nov 25 2004
Allan SM, Rothwell NJ (2003) Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 358:1669–1677
Anisman H, Merali Z (2002) Cytokines, stress, and depressive illness. Brain Behav Immun 16:513–524
Asnis GM, De La Garza R II, Kohn SR, Reinus JF, Henderson M, Shah J (2003) IFN-induced depression: a role for NSAIDs. Psychopharmacol Bull 37:29–50
Aubry JM, Turnbull AV, Pozzoli G, Rivier C, Vale W (1997) Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary. Endocrinology 138:1621–1626
Bluthe RM, Crestani F, Kelley KW, Dantzer R (1992) Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF. Ann N Y Acad Sci 650:268–275
Buller KM, Xu Y, Day TA (1998) Indomethacin attenuates oxytocin and hypothalamic–pituitary–adrenal axis responses to systemic interleukin-1 beta. J Neuroendocrinol 10:519–528
Castanon N, Bluthe RM, Dantzer R (2001) Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology 154:50–60
Castanon N, Leonard BE, Neveu PJ, Yirmiya R (2002) Effects of antidepressants on cytokine production and actions. Brain Behav Immun 16:569–574
Charlton BG (2000) The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic. Med Hypoth 54:126–130
Crestani F, Seguy F, Dantzer R (1991) Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res 542:330–335
De La Garza R II (2004) Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev (invited review, in press)
De La Garza R II, Fabrizio KR, Radoi GE, Vlad T, Asnis GM (2004a) The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release. Behav Brain Res 149:77–85
De La Garza R II, Pedrosa E, Stearns C, Asnis GM (2004b) Chronic lypopolysaccharide results in tolerance to alterations to basic reward behavior, body weight, and food and water consumption. Biol Psychiatry 55(8), Supplement 1:59s
Dunn AJ, Chuluyan HE (1992) The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection. Life Sci 51:219–225
Dunn AJ, Swiergiel AH (2000) The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia. Brain Behav Immun 14:141–152
Dunn AJ, Swiergiel AH (2001) The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment. Neuroimmunomodulation 9:163–169
Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci 100:13632–13637
Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL (1984) Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 141:619–627
Hart BL (1988) Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12:123–137
Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501
Irwin M (2002) Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun 16:1–16
Johnson PM, Vogt SK, Burney MW, Muglia LJ (2002) COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. Am J Physiol Endocrinol Metab 282:E650–E656
Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR (2003) Cytokine-induced sickness behavior. Brain Behav Immun 17:S112–S118
Kent S, Bluthe RM, Kelley KW, Dantzer R (1992) Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13:24–28
Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25:154–159
Kronfol Z (2002) Immune dysregulation in major depression: a critical review of existing evidence. Int J Neuropsychopharmacol 5:333–343
Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683–694
Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001) Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 21:199–206
Lacroix S, Rivest S (1997) Functional circuitry in the brain of immune-challenged rats: partial involvement of prostaglandins. J Comp Neurol 387:307–324
Langhans W, Savoldelli D, Weingarten S (1993) Comparison of the feeding responses to bacterial lipopolysaccharide and interleukin-1 beta. Physiol Behav 53:643–649
Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370–379
Larson SJ, Dunn AJ (2001) Behavioral effects of cytokines. Brain Behav Immun 15:371–387
Laye S, Parnet P, Goujon E, Dantzer R (1994) Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res 27:157–162
Lenczowski MJ, Van Dam AM, Poole S, Larrick JW, Tilders FJ (1997) Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS. Am J Physiol 273:R1870–R1877
Leonard BE (2001) The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 25:767–780
Licinio J, Wong ML (1999) The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4:317–327
Licinio J, Kling MA, Hauser P (1998) Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes. Semin Oncol 25:30–38
Maes M (1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25–46
Malberg JE, Duman RS (2003) Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28:1562–1571
Merali Z, Brennan K, Brau P, Anisman H (2003) Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for “free chow” and “earned” sucrose intake. Psychopharmacology 165:413–418
Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760–1765
Morimoto A, Murakami N, Nakamori T, Sakata Y, Watanabe T (1989) Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1. J Physiol 411:245–256
Nagano I, Takao T, Nanamiya W, Takemura T, Nishiyama M, Asaba K, Makino S, De Souza EB, Hashimoto K (1999) Differential effects of one and repeated endotoxin treatment on pituitary-adrenocortical hormones in the mouse: role of interleukin-1 and tumor necrosis factor-alpha. Neuroimmunomodulation 6:284–292
National Institute of Mental Health (2002) Methods and welfare considerations in behavioral research with animals: report of a National Institutes of Health Workshop. In: Morrison AR, Evans HL, Ator NA, Nakamura RK (eds) NIH publication no. 02-5083. US Government Printing Office, Washington
Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342–1344
Niimi M, Wada Y, Sato M, Takahara J, Kawanishi K (1997) Effect of continuous intravenous injection of interleukin-6 and pretreatment with cyclooxygenase inhibitor on brain c-fos expression in the rat. Neuroendocrinology 66:47–53
Okamoto T (2002) NSAID zaltoprofen improves the decrease in body weight in rodent sickness behavior models: proposed new applications of NSAIDs. Int J Mol Med 9:369–372
Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391–404
Parsadaniantz SM, Lebeau A, Duval P, Grimaldi B, Terlain B, Kerdelhue B (2000) Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic–pituitary–adrenal axis induced by interleukin-1beta in the male rat. J Neuroendocrinol 12:766–773
Preil J, Muller MB, Gesing A, Reul JM, Sillaber I, van Gaalen MM, Landgrebe J, Holsboer F, Stenzel-Poore M, Wurst W (2001) Regulation of the hypothalamic–pituitary–adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology 142:4946–4955
Raison CL, Miller AH (2001) The neuroimmunology of stress and depression. Semin Clin Neuropsychiatr 6:277–294
Raison CL, Miller AH (2003) When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160:1554–1565
Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452
Reichenberg A, Kraus T, Haack M, Schuld A, Pollmacher T, Yirmiya R (2002) Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion. Psychoneuroendocrinology 27:945–956
Ribot E, Lafon P, Ciofi P, Sarrieau A, Tramu G, Corio M (2003) Prostaglandins mediate lipopolysaccharide effects upon cholecystokinin and neurotensin phenotypes in neuroendocrine corticotropin-releasing hormone neurons: in situ hybridization evidence in the rat. Neuroscience 120:643–648
Rivest S, Laflamme N (1995) Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. J Neuroendocrinol 7:501–525
Rivier CL, Grigoriadis DE, Rivier JE (2003) Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology 144:2396–2403
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805–809
Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093–1102
Swiergiel AH, Dunn AJ (2001) Cyclooxygenase 1 is not essential for hypophagic responses to interleukin-1 and endotoxin in mice. Pharmacol Biochem Behav 69:659–663
Swiergiel AH, Dunn AJ (2002) Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. J Pharmacol Exp Ther 302:1031–1036
Swiergiel AH, Smagin GN, Dunn AJ (1997) Influenza virus infection of mice induces anorexia: comparison with endotoxin and interleukin-1 and the effects of indomethacin. Pharmacol Biochem Behav 57:389–396
Tilders FJ, DeRijk RH, Van Dam AM, Vincent VA, Schotanus K, Persoons JH (1994) Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology 19:209–232
Turnbull AV, Rivier C (1996) Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic–pituitary–adrenal response to acute local inflammation in the rat. Endocrinology 137:455–463
Turrin NP, Gayle D, Ilyin SE, Flynn MC, Langhans W, Schwartz GJ, Plata-Salaman CR (2001) Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull 54:443–453
Uehara A, Ishikawa Y, Okumura T, Okamura K, Sekiya C, Takasugi Y, Namiki M (1989) Indomethacin blocks the anorexic action of interleukin-1. Eur J Pharmacol 170:257–260
Wan W, Wetmore L, Sorensen CM, Greenberg AH, Nance DM (1994) Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res Bull 34:7–14
Weidenfeld J, Yirmiya R (1996) Effects of bacterial endotoxin on the glucocorticoid feedback regulation of adrenocortical response to stress. Neuroimmunomodulation 3:352–357
Xu S, Guo S, Jiang X, Yin Q, Umezawa T, Hisamitsu T (2003) Effect of indomethacin on the c-fos expression in AVP and TH neurons in rat brain induced by lipopolysaccharide. Brain Res 966:13–18
Yirmiya R (1996) Endotoxin produces a depressive-like episode in rats. Brain Res 711:163–174
Yirmiya R, Weidenfeld J, Pollak Y, Morag M, Morag A, Avitsur R, Barak O, Reichenberg A, Cohen E, Shavit Y, Ovadia H (1999) Cytokines, “depression due to a general medical condition,” and antidepressant drugs. Adv Exp Med Biol 461:283–316
Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M, Weihe E, Weidenfeld J (2001) Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24:531–544